HARVARD BIOSCIENCE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $1.00K, a 99.38% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $47.00K, a 73.30% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-12-31 was $161.00K, a 22.97% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $47.00K, a 86.05% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $337.00K, a 20.52% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $424.00K, a 9.59% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $469.00K, a 7.32% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $47.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | $47.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $337.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $176.00K 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $424.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | |
| 2023-06-30 | $215.00K 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $469.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | |
| 2022-06-30 | $239.00K 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $437.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | |
| 2021-06-30 | $202.00K 10-Q · filed 2022-08-04 | |
| 2020-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $347.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $167.00K 10-Q · filed 2021-08-06 | |
| 2019-12-31 | $166.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $325.00K 10-K/A · filed 2021-03-17 |
| 2019-09-30 | $70.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $89.00K 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $160.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $11.00K 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $140.00K 10-K · filed 2019-03-18 | |
| 2016-12-31 | $196.00K 10-K · filed 2018-03-16 | |
| 2015-12-31 | $208.00K 10-K · filed 2018-03-16 | |
| 2014-12-31 | $228.00K 10-K · filed 2017-03-17 | |
| 2013-12-31 | $194.00K 10-K · filed 2016-04-29 | |
| 2012-12-31 | $192.00K 10-K · filed 2015-03-12 | |
| 2011-12-31 | $167.00K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $154.00K 10-K · filed 2013-03-18 | |
| 2009-12-31 | $100.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |